Innate and Peripheral Immune Alterations after Traumatic Brain Injury Are Regulated in a Gut Microbiota-Dependent

Marta Celorrio1, Kirill Shumilov1, Rachel Rodgers2

  • 1Department of Pediatrics, and Division of Infectious Diseases, Edison Family Center for Genome Sciences and Systems Biology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.

Journal of Neurotrauma
|October 19, 2022
PubMed

Insights

Traumatic brain injury (TBI) disrupts the gut microbiome. Modulating gut bacteria, not antibiotics directly, impacts neuroinflammation and neurogenesis after TBI, suggesting new therapeutic avenues.

Area of Science:

  • Neuroscience
  • Microbiology
  • Immunology

Background:

  • Traumatic brain injury (TBI) is linked to gut microbiome disruption.
  • Antibiotic use post-TBI alters gut microbiota, neuroinflammation, neurogenesis, and memory.
  • The direct vs. indirect effects of antibiotics on TBI's brain response remain unclear.

Purpose of the Study:

  • To determine if antibiotic effects on TBI brain response are direct or mediated by gut microbiota changes.
  • To investigate the role of gut microbiota modulation in TBI-induced neuroinflammation and neurogenesis.

Main Methods:

  • Fecal microbiota transplantation (FMT) from antibiotic-treated mice to germ-free (GF) mice before TBI.
  • Antibiotic exposure in specific pathogen-free (SPF) mice before TBI, with antibiotics discontinued 72 hours prior.
  • Analysis of gut bacterial diversity, microglial activation, T cell infiltration, and neurogenesis post-TBI.

Main Results:

  • GF mice receiving FMT from antibiotic-treated donors (GF-VNAM) showed reduced gut bacterial diversity.
  • GF-VNAM mice exhibited increased microglial activation, reduced T cell infiltration, and decreased neurogenesis at 7 days post-TBI.
  • SPF mice exposed to antibiotics pre-injury showed similar neuroinflammation and neurogenesis alterations compared to controls.

Conclusions:

  • Gut microbiota composition significantly modulates neuroinflammation and neurogenesis following TBI.
  • These findings implicate the gut microbiota as a key mediator in the brain's response to TBI.
  • Targeting the gut microbiota presents a potential neuroprotective therapeutic strategy for TBI.

Related Concept Videos